PIEZO1 and cerebral small vessel disease: Brain capillary ECs from mouse models of Alzheimer’s disease, cerebral small vessel disease, or Piezo1 gain-of-function mutation exhibited higher Piezo1 activity, that was corrected by exogenous ex vivo PIP2 application.